Cozzone et al. reported impaired insulin signaling in skeletal muscles of T2D patients due to deregulated serine phosphorylation of Akt2 and Akt3 (and threonine phosphorylation of Akt1) [9]. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.